SCHEMBL20569862

SCHEMBL20569862

C[C@@H](CO)N1CCNCC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SLC6A2 P23975 5/20 0.32
SLC6A4 P31645 5/20 0.32
CYP2D6 P10635 2/20 0.32
SLC6A3 Q01959 2/20 0.32
HTR7 P34969 1/20 0.32
KCNH2 Q12809 1/20 0.32
CYP19A1 P11511 1/20 0.31
HSD17B10 Q99714 1/20 0.31
OPRD1 P41143 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM1 P11229 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15471 1.00 HRH3 (0.37) HRH3CHRM5CHRM3SMN1; SMN2SIGMAR1
Hydrochloric Acid SCHEMBL64916 0.98 SMN1; SMN2 (0.38) HRH3CHRM5CHRM3SMN1; SMN2SIGMAR1
SCHEMBL9813407 0.98 HRH3 (0.36) HRH3CHRM5CHRM3SMN1; SMN2SIGMAR1
Methyl Alcohol SCHEMBL27940927 0.98 HRH3 (0.36) HRH3CHRM5CHRM3SMN1; SMN2SIGMAR1
Pyridine SCHEMBL28163287 0.84 SLC6A4 (0.42) HRH3MEN1KMT2ASLC6A2SLC6A4
SCHEMBL4260116 0.82 CHRM5 (0.35) CHRM5CHRM3SMN1; SMN2SIGMAR1MEN1
SCHEMBL11140109 0.82 TSHR (0.39) HRH3MEN1KMT2A
SCHEMBL11535589 0.82
SCHEMBL12337822 0.82 TSHR (0.39) HRH3MEN1KMT2A
Tert-Butyl Formate SCHEMBL27787993 0.80 TDP1 (0.39) HRH3CHRM5CHRM3SIGMAR1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630769-A1 NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF Topadur Pharma AG (CH) 2020-04-08 EP disclosed
WO-2018215433-A1 NOVEL DUAL MODE OF ACTION SOLUBLE GUANYLATE CYCLASE ACTIVATORS AND PHOSPHODIESTERASE INHIBITORS AND USES THEREOF TOPADUR PHARMA AG (CH) 2018-11-29 WO disclosed